Corrigendum to “Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis” [Eur J Cancer 47 (12) (2011) 1826–1836]

✍ Scribed by Stephen J. Clarke; Sonia Yip; Chris Brown; Guy A. van Hazel; David T. Ransom; David Goldstein; G. Mark Jeffrey; Niall C. Tebbutt; Martin Buck; Raymond M. Lowenthal; Amy Boland; Val Gebski; John Zalcberg; R. John Simes

• Book ID: 116430962
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 145 KB
• Volume: 48
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2011.12.001